ZA957794B - [1.2.4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use - Google Patents
[1.2.4]triazolo[4,3-a]quinoxalinone derivatives their preparation and useInfo
- Publication number
- ZA957794B ZA957794B ZA957794A ZA957794A ZA957794B ZA 957794 B ZA957794 B ZA 957794B ZA 957794 A ZA957794 A ZA 957794A ZA 957794 A ZA957794 A ZA 957794A ZA 957794 B ZA957794 B ZA 957794B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- triazolo
- independently
- preparation
- pox
- Prior art date
Links
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical class C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002883 imidazolyl group Chemical group 0.000 abstract 2
- NBXOKUUXBOFVIJ-UHFFFAOYSA-N 2h-[1,2,4]triazolo[4,3-a]quinoxalin-1-one Chemical class C1=CC=C2N3C(=O)NN=C3C=NC2=C1 NBXOKUUXBOFVIJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000002964 excitative effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 239000002858 neurotransmitter agent Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK106694 | 1994-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA957794B true ZA957794B (en) | 1996-05-14 |
Family
ID=8100607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA957794A ZA957794B (en) | 1994-09-16 | 1995-09-15 | [1.2.4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0781282B1 (xx) |
| JP (1) | JPH10506620A (xx) |
| KR (1) | KR970706285A (xx) |
| CN (1) | CN1193973A (xx) |
| AT (1) | ATE183186T1 (xx) |
| AU (1) | AU694554B2 (xx) |
| CA (1) | CA2200056A1 (xx) |
| CZ (1) | CZ284930B6 (xx) |
| DE (1) | DE69511420T2 (xx) |
| DK (1) | DK0781282T3 (xx) |
| ES (1) | ES2138233T3 (xx) |
| FI (1) | FI971076A (xx) |
| GR (1) | GR3031788T3 (xx) |
| HU (1) | HUT76802A (xx) |
| IL (1) | IL115299A0 (xx) |
| NO (1) | NO308797B1 (xx) |
| NZ (1) | NZ292108A (xx) |
| PL (1) | PL319175A1 (xx) |
| SK (1) | SK282457B6 (xx) |
| TW (1) | TW397835B (xx) |
| WO (1) | WO1996008493A1 (xx) |
| ZA (1) | ZA957794B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| EP1050535A4 (en) | 1997-11-11 | 2001-04-25 | Ono Pharmaceutical Co | CONDENSED PYRAZINE DERIVATIVES |
| ES2612954T3 (es) | 2009-03-05 | 2017-05-19 | Astellas Pharma Inc. | Compuestos de quinoxalina |
| MX2013002579A (es) | 2010-09-07 | 2013-04-29 | Astellas Pharma Inc | Compuesto de quinoxalina. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4354027A (en) * | 1980-05-19 | 1982-10-12 | Usv Pharmaceutical Corporation | Triazoloquinoxalin-4-ones |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
| DK162491D0 (da) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne |
| WO1993020077A1 (en) * | 1992-04-03 | 1993-10-14 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
| DK31093D0 (xx) * | 1993-03-19 | 1993-03-19 | Novo Nordisk As | |
| NZ266127A (en) * | 1993-05-06 | 1997-11-24 | Novo Nordisk As | Quinoxaline derivatives, preparation and medicaments |
-
1995
- 1995-09-12 KR KR1019970701669A patent/KR970706285A/ko not_active Application Discontinuation
- 1995-09-12 CZ CZ97753A patent/CZ284930B6/cs not_active IP Right Cessation
- 1995-09-12 AU AU33808/95A patent/AU694554B2/en not_active Ceased
- 1995-09-12 EP EP95930410A patent/EP0781282B1/en not_active Expired - Lifetime
- 1995-09-12 CA CA002200056A patent/CA2200056A1/en not_active Abandoned
- 1995-09-12 NZ NZ292108A patent/NZ292108A/xx unknown
- 1995-09-12 HU HU9701241A patent/HUT76802A/hu unknown
- 1995-09-12 SK SK334-97A patent/SK282457B6/sk unknown
- 1995-09-12 DK DK95930410T patent/DK0781282T3/da active
- 1995-09-12 PL PL95319175A patent/PL319175A1/xx unknown
- 1995-09-12 WO PCT/DK1995/000365 patent/WO1996008493A1/en not_active Application Discontinuation
- 1995-09-12 AT AT95930410T patent/ATE183186T1/de not_active IP Right Cessation
- 1995-09-12 DE DE69511420T patent/DE69511420T2/de not_active Expired - Fee Related
- 1995-09-12 CN CN95195697A patent/CN1193973A/zh active Pending
- 1995-09-12 TW TW084109492A patent/TW397835B/zh not_active IP Right Cessation
- 1995-09-12 JP JP8509828A patent/JPH10506620A/ja active Pending
- 1995-09-12 ES ES95930410T patent/ES2138233T3/es not_active Expired - Lifetime
- 1995-09-14 IL IL11529995A patent/IL115299A0/xx unknown
- 1995-09-15 ZA ZA957794A patent/ZA957794B/xx unknown
-
1997
- 1997-03-14 FI FI971076A patent/FI971076A/fi unknown
- 1997-03-14 NO NO971187A patent/NO308797B1/no not_active IP Right Cessation
-
1999
- 1999-11-09 GR GR990402881T patent/GR3031788T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU694554B2 (en) | 1998-07-23 |
| CN1193973A (zh) | 1998-09-23 |
| FI971076A (fi) | 1997-05-13 |
| SK33497A3 (en) | 1998-02-04 |
| WO1996008493A1 (en) | 1996-03-21 |
| GR3031788T3 (en) | 2000-02-29 |
| DK0781282T3 (da) | 2000-02-28 |
| NO971187D0 (no) | 1997-03-14 |
| CZ284930B6 (cs) | 1999-04-14 |
| DE69511420D1 (de) | 1999-09-16 |
| NO971187L (no) | 1997-05-15 |
| SK282457B6 (sk) | 2002-02-05 |
| KR970706285A (ko) | 1997-11-03 |
| ES2138233T3 (es) | 2000-01-01 |
| CZ75397A3 (en) | 1997-08-13 |
| AU3380895A (en) | 1996-03-29 |
| FI971076A0 (fi) | 1997-03-14 |
| NZ292108A (en) | 1999-02-25 |
| DE69511420T2 (de) | 2000-03-30 |
| PL319175A1 (en) | 1997-08-04 |
| ATE183186T1 (de) | 1999-08-15 |
| CA2200056A1 (en) | 1996-03-21 |
| EP0781282B1 (en) | 1999-08-11 |
| IL115299A0 (en) | 1995-12-31 |
| EP0781282A1 (en) | 1997-07-02 |
| JPH10506620A (ja) | 1998-06-30 |
| HUT76802A (en) | 1997-11-28 |
| TW397835B (en) | 2000-07-11 |
| NO308797B1 (no) | 2000-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1070056T1 (en) | Phthalazinone pde iii/iv inhibitors | |
| CA2085733A1 (en) | Polycyclic guanine derivatives | |
| HUP0001993A2 (hu) | Fungicid hatású (trifluor-metil-alkil)-amino-triazol 0[1,5-a]pirimidin-származékok, előállításuk és alkalmazásuk | |
| ATE179698T1 (de) | Pyrrolidin- und oxazolidin derivate , ihre herstellung und ihre verwendung als thrombocyten- aggregations-hemmer | |
| PL338339A1 (en) | Novel derivatives of tetrazole | |
| IL118167A0 (en) | Pyrazolo (1,5a) pyrimidines their preparation and use | |
| DE60127845D1 (de) | Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel | |
| DE69316910D1 (de) | Neue vitamin d derivate | |
| AU4205197A (en) | New thiazole derivatives with phosphodiesterase-inhibiting effect | |
| PL356541A1 (en) | 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity | |
| IL115299A0 (en) | Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use | |
| DE60036558D1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
| TW216795B (en) | 3-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazoline derivatives, the preparation and use thereof | |
| TR200100133T2 (tr) | FKBP İnhibitörleri | |
| CA2120782A1 (en) | Thioxanthenone antitumor agents | |
| TW334340B (en) | Preparation for pyrazolyl derivatives | |
| CA2070120A1 (en) | Thioxanthenone antitumor agents | |
| GR3033642T3 (en) | [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE | |
| CA2070799A1 (en) | Thioxanthenone antitumor agents | |
| ZA931099B (en) | Heterocyclic compounds their use and preparation | |
| DE60003560D1 (de) | 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate | |
| IL169334A0 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors |